Biochemical/immunochemical biomarkers of osteoarthritis: utility for prediction of incident or progressive osteoarthritis (Q35578072)

9 August 2017

1 reference

title

Biochemical/immunochemical biomarkers of osteoarthritis: utility for prediction of incident or progressive osteoarthritis (English)

1 reference

9 August 2017

0 references

0 references

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00056-5

29 March 2024

author name string

A. Robin Poole

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:14603584

29 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14603584

29 March 2024

publication date

1 November 2003

1 reference

full work available at URL

9 August 2017

https://api.elsevier.com/content/article/PII:S0889857X03000565?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00056-5

https://api.elsevier.com/content/article/PII:S0889857X03000565?httpAccept=text/plain

29 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00056-5

Rheumatic Diseases Clinics of North America

29 March 2024

published in

1 reference

9 August 2017

volume

29

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

803-818

1 reference

Gd-DTPA2- as a measure of cartilage degradation

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1)

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Analysis of collagenase-cleavage of type II collagen using a neoepitope ELISA.

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Collagen type II C-telopeptide fragments as an index of cartilage degradation

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Evidence for altered synthesis of type II collagen in patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Osteoarthritis in cynomolgus macaques II. Detection of modulated proteoglycan epitopes in cartilage and synovial fluid

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis.

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

C-reactive protein as a biomarker of emergent osteoarthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

The role of the chondrocyte in osteoarthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Elevated serum C-reactive protein levels in osteoarthritis.

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Synovial fluid and plasma levels of cartilage matrix glycoprotein in arthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

The associations of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in pre- and perimenopausal women

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Changes in joint cartilage aggrecan after knee injury and in osteoarthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: The Johnston county osteoarthritis project

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Serum and synovial fluid osteocalcin (bone gla protein) levels in joint disease

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Tissue inhibitor of metalloprotease-1 (TIMP-1) serum level may predict progression of hip osteoarthritis

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)50056-5

7 January 2021

Serum concentrations of hyaluronan and proteoglycan in joint disease. Lack of association

series ordinal

58

1 reference

https://api.crossref.org/works/10.1016/S0889-857X(03)00056-5

29 March 2024

Identifiers

1 reference

9 August 2017

1 reference